Cybin (TSE:CYBN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cybin Inc., a leader in neuropsychiatry treatments, announced that their Chief Medical Officer will participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. The company specializes in innovative therapies for mental health conditions, including a psilocin program for depression and a DMT program for anxiety that are advancing through clinical trials.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
